紫外线A核黄素角膜交联疗法是近年来兴起的通过紫外线A光和光敏剂核黄素诱导角膜基质胶原纤维相互交联,从而提高角膜硬度和改变生物学性能的新方法,临床上最早被应用于治疗圆锥角膜等角膜扩张性疾病。随着研究深入,角膜交联的模式不断创新,临床应用更加广泛。本文就角膜交联疗法模式的改进和临床应用等相关研究进展进行综述。 (中华眼科杂志,2015,51:715-720)
UVA-riboflavin collagen crosslinking was introduced as a clinical application to stabilize the cornea by inducing crosslinks within and between collagen fibers. It has been shown clinically to arrest the progression of keratoconic ectasia. With further researches, the technical methods of collagen crosslinking have been improved, and the treatment range has been increased. This paper covers the researches on the innovative techniques and applications of collagen crosslinking. (Chin J Ophthalmol, 2015, 51: 715-720)
朱奕睿,陈蔚. 紫外线A核黄素角膜交联的研究进展[J]. 中华眼科杂志,2015,51(9):715-720.
DOI:10.3760/cma.j.issn.0412-4081.2015.09.019版权归中华医学会所有。
未经授权,不得转载、摘编本刊文章,不得使用本刊的版式设计。
除非特别声明,本刊刊出的所有文章不代表中华医学会和本刊编委会的观点。

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。